Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 481 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
481
Total Funding
$2.5B
Avg Funding
$99.5M
Cities
20

Export 481 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Watertown, United States
$185.0M
raised

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Newport Beach, United States
$5.0M
raised

Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$100.0M
raised

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Westlake Village, United States
$150.0M
raised

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$125.0M
raised

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Freehold, United States
$9.8M
raised

Avalon GloboCare is a biotech company that develops diagnostics, cellular therapies, along with health tech products.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Altrincham, United Kingdom
$200.0M
raised

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$150.0M
raised

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wayne, United States
$200.0M
raised

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Henderson, United States
$144.0M
raised

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$150.0M
raised

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$40.0M
raised

Omega Therapeutics offers a proprietary epigenomic programming platform.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$200.0M
raised

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Saintes, Belgium
$540K
raised

BioSenic is a forward-thinking firm that aims to address critical unmet medical needs.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Gaithersburg, United States
$3.7M
raised

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$230.0M
raised

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Victoria, Canada
$63.2M
raised

Eupraxia is a clinical-stage biotech company developing locally delivered, extended-release alternatives to currently approved drugs.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$9.6M
raised

Petros Pharmaceuticals focuses on identifying, developing, acquiring, and commercializing novel therapeutics for men's health issues.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Morristown, United States
$12.0M
raised

Cingulate Therapeutics uses a unique combination of delivery technology and proven medications that creates an unmatched release profile.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Minnesota City, United States
$10.9M
raised

Calyxt is an agbiotech company that focuses on developing healthier crops.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$400.0M
raised

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Tarpon Springs, United States
$3.3M
raised

A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Red Bank, United States
$35.0M
raised

Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Hamilton, Canada
$60.0M
raised

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lund, Sweden
$1.4M
raised

Carbiotix is a pre-clinical stage therapeutics company focusing on low-cost gut health testing and microbiome modulators.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 301 to 325 of 481 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 481 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

481 Biotechnology Post-IPO Equity Startups (September 2026) — Page 13 | VCBacked